# Bridging the gap: Prevotella/Segatella's impact on gut barrier function and advanced cultivation strategies to realize the uses in gut health

**Authors:** Shuang Wang, Tao Zhou, Xiuqi Wang, Jiangchao Zhao, Xiaofan Wang

PMC · DOI: 10.1080/19490976.2026.2638001 · Gut Microbes · 2026-03-02

## TL;DR

This paper reviews the role of Prevotella and Segatella in gut health and outlines cultivation strategies to harness their probiotic potential.

## Contribution

The paper provides a comprehensive review of cultivation methods and molecular mechanisms of Prevotella/Segatella in gut barrier function.

## Key findings

- Prevotella and Segatella modulate gut microbial composition and host metabolic pathways.
- 23 isolation and cultivation approaches for Prevotella/Segatella are summarized.
- Multi-omics approaches are emphasized for strain-specific functional profiling.

## Abstract

Prevotella and Segatella are important, keystone genera in the gut microbiota, renowned for their exceptional fiber-degrading capacity. These genera critically modulate gut microbial composition, influence host metabolic pathways and gut barrier function, and exhibit formidable ecological niche competitiveness, underscoring their pivotal role in gut ecosystem dynamics. While they dominate healthy gut microbiomes, their probiotic potential on epithelial barrier function has been disproportionately overlooked. This review comprehensively elucidates their microbial eco-profiling and the underlying molecular mechanisms in sustaining intestinal barrier function, considering physical, chemical, biological, and microbiological dimensions, thereby providing insights relevant to the prevention and treatment of intestinal diseases such as inflammatory bowel disease, irritable bowel syndrome, and metabolic disorders. Most importantly, we have summarized 23 current commercial and research-based isolation and cultivation approaches for Prevotella/Segatella, integrating the emerging high-throughput methodologies to expand the available strain repertoire. We also emphasize the critical need for subsequent research to characterize strain-specific functional profiles through multi-omics approaches, which will be essential for developing targeted and personalized microbial therapeutics.

## Linked entities

- **Diseases:** inflammatory bowel disease (MONDO:0005265), irritable bowel syndrome (MONDO:0005052)
- **Species:** Prevotella (taxon 838), Segatella (taxon 2974251)

## Full-text entities

- **Diseases:** PSC (MESH:D015209), preterm labor (MESH:D007752), multiple sclerosis (MESH:D009103), atopic dermatitis (MESH:D003876), intestinal diseases (MESH:D007410), constipation (MESH:D003248), hypersensitivity (MESH:D004342), Irritable Bowel Syndrome (MESH:D043183), gastric mucosal lesions (MESH:D013272), Brain Heart Infusion (MESH:D000075662), IBD (MESH:D015212), mucosal damage (MESH:D052016), bone loss (MESH:D001847), dry eye (MESH:D015352), toxicity (MESH:D064420), cardiovascular disease (MESH:D002318), Infections (MESH:D007239), COVID-19 (MESH:D000086382), endocrine-associated (MESH:D004700), colitis (MESH:D003092), hypothyroidism (MESH:D007037), colorectal cancer (MESH:D015179), gut impairment (MESH:C536735), vascular calcification (MESH:D061205), arthritis (MESH:D001168), rheumatoid arthritis (MESH:D001172), diarrheal diseases (MESH:D004403), neurological deficits (MESH:D009461), Metabolic dysfunction (MESH:D008659), psoriasis (MESH:D011565), chronic obstructive pulmonary disease (MESH:D029424), diarrhea (MESH:D003967), MAFLD (MESH:D005234), primary sclerosing (MESH:D012598), Spinal Arthritis (MESH:D025241), dysbiosis (MESH:D064806), diabetes (MESH:D003920), tumor (MESH:D009369), inflammation (MESH:D007249), sarcopenia (MESH:D055948), periodontitis (MESH:D010518), fibrosis (MESH:D005355), hyperglycemia (MESH:D006943)
- **Chemicals:** glucose (MESH:D005947), Indole (MESH:C030374), SCFA (MESH:D005232), beta-glucans (MESH:D047071), Cy5 (MESH:C085321), acetate (MESH:D000085), tryptophan (MESH:D014364), GUO (MESH:D006151), indole-3-carboxaldehyde (MESH:C012381), indole-3-acetic acid (MESH:C030737), cellulose (MESH:D002482), LPS (MESH:D008070), vitamin K1 (MESH:D010837), CO2 (MESH:D002245), butyric acid (MESH:D020148), Propionate (MESH:D011422), starch (MESH:D013213), XOS (MESH:C570991), carbohydrate (MESH:D002241), bicarbonate (MESH:D001639), Butyrate (MESH:D002087), macrolide (MESH:D018942), Amino Acid (MESH:D000596), indole-3-lactate (MESH:C024139), IS (MESH:D007200), tetracycline (MESH:D013752), Na+ (MESH:D012964), FL1 (-), bile acids (MESH:D001647), ethanol (MESH:D000431), kanamycin (MESH:D007612), Hemicellulose (MESH:C007916), hyaluronic acid (MESH:D006820), bromocresol purple (MESH:D001962), inulin (MESH:D007444), Vancomycin (MESH:D014640), mannans (MESH:D008351), arachidonic acid (MESH:D016718), xylan (MESH:D014990), agar (MESH:D000362), glucomannans (MESH:C022901), carbon (MESH:D002244), FITC (MESH:D016650), Polysaccharide (MESH:D011134), pectin (MESH:D010368), galactomannan (MESH:C012990), antimicrobial peptides (MESH:D000089882), Succinate (MESH:D019802), doxycycline (MESH:D004318), galactans (MESH:D005685), azithromycin (MESH:D017963), chondroitin sulfate (MESH:D002809), rhamnogalacturonan-II (MESH:C042492), NaCl (MESH:D012965)
- **Species:** Prevotella melaninogenica (species) [taxon 28132], gut metagenome (species) [taxon 749906], Prevotella jejuni (species) [taxon 1177574], Fusobacterium nucleatum (species) [taxon 851], Hoylesella buccalis (species) [taxon 28127], Segatella bryantii (species) [taxon 77095], P. nigrescens [taxon 413295], Prescottella equi (species) [taxon 43767], Hoylesella nanceiensis (species) [taxon 425941], Clostridium (genus) [taxon 1485], Hoylesella loescheii (species) [taxon 840], Homo sapiens (human, species) [taxon 9606], Faecalibacterium prausnitzii (species) [taxon 853], Rattus norvegicus (brown rat, species) [taxon 10116], Segatella salivae (species) [taxon 228604], Staphylococcus aureus (species) [taxon 1280], Prevotella corporis (species) [taxon 28128], Syntrophomonas bryantii (species) [taxon 2082], Butyrivibrio fibrisolvens (species) [taxon 831], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Segatella copri (species) [taxon 165179], Parabacteroides merdae (species) [taxon 46503], Porphyromonas gingivalis (species) [taxon 837], Streptobacillus moniliformis (species) [taxon 34105], Akkermansia muciniphila (species) [taxon 239935], Xylanibacter ruminicola (species) [taxon 839], Streptococcus (genus) [taxon 1301], Leyella stercorea (species) [taxon 363265], Ruminococcus (genus) [taxon 1263], Prevotella bivia (species) [taxon 28125], Bacteroides thetaiotaomicron (species) [taxon 818], Allobaculum (genus) [taxon 174708], Roseburia (genus) [taxon 841], Enterococcus (genus) [taxon 1350], Human immunodeficiency virus 1 (no rank) [taxon 11676], Bacteroides ovatus (species) [taxon 28116], Prevotella falsenii (species) [taxon 515414], Hoylesella saccharolytica (species) [taxon 633701], Phascolarctobacterium (genus) [taxon 33024], Prevotella intermedia (species) [taxon 28131], Desulfovibrio (genus) [taxon 872], Salmonella enterica (species) [taxon 28901], Prevotella (genus) [taxon 838], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], Prevotella conceptionensis (species) [taxon 340486], Dialister (genus) [taxon 39948], Heyndrickxia coagulans (species) [taxon 1398], Ligilactobacillus murinus (species) [taxon 1622], Prevotella histicola (species) [taxon 470565], Prevotella veroralis (species) [taxon 28137], Bifidobacterium longum (species) [taxon 216816]
- **Mutations:** M416
- **Cell lines:** BgF5_2 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_B6KL)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12959208/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12959208/full.md

## References

221 references — full list in the complete paper: https://tomesphere.com/paper/PMC12959208/full.md

---
Source: https://tomesphere.com/paper/PMC12959208